|
John Brazier is a Professor of Health Economics at the University of Sheffield. With more than twenty five years' experience of conducting economic evaluations for policy makers, he has a particular interest in the measurement and valuation of health where he has published widely (n>200). He has developed generic (SF-6D) and condition preference-based measures of health (e.g. cancer, asthma, diabetes, vision, mental health) and more recently looking at the role of well-being measures. He is Director of the Economic Evaluation in Health and Care Intervention Policy Research Unit (EEPRU) and advises policy makers on measuring and valuing benefits for economic evaluation and a member of the EuroQol group.
Julie Ratcliffe is a Professor of Health Economics at Flinders University with a strong track record in health economics research. . She has over 100 papers in peer reviewed journals, including some of the most prestigious international health journals such as the British Medical Journal, Health Economics, and Social Science and Medicine and has co-authored 32 commissioned reports and discussion papers. She is currently Head of Flinders Health Economics Group (Flinders Health Care and Workforce Innovation) and Chair of the Flinders Centre for Clinical Change and Health Care Research focusing in the translation of evidence to clinical outcomes across multiple health care disciplines.
Joshua Salomon's research focuses on priority-setting in global health, within three main substantive areas, measurement and valuation of measurement and valuation of health outcomes, modeling patterns and trends in major causes of global mortality and disease burden and evaluation of health policies and interventions. He is an investigator on projects funded by NIH and the Gates Foundation relating to comparability of health measures; the global burden of disease; modeling of infectious and chronic diseases and interventions; and evaluating the potential impact and cost effectiveness of new health technologies.
Aki Tsuchiya is a Professor of Health Economics at the University of Sheffield. She has worked in the area of health state valuation methodology (use of DCE with duration, development of lead time TTO and non-iterative TTO) and normative health economics (inequality aversion, social value of QALYs). She has extensive experience teaching health economics at undergraduate level (to economics students) and at postgraduate level (to health economics students). She is a member of the EuroQol Group. |
